Vitiligo typically starts as small, pale patches of skin that gradually lose their color until they become milky white. These patches most often first appear on the hands, face, and areas around body openings like the mouth, eyes, and genitals. The condition can begin at any age, but roughly one-third of cases start early in life (average age around 10) while two-thirds develop later (average age around 34).
What the First Patches Look Like
The earliest sign is a subtle loss of pigment in a small area of skin. At first, the spot may look slightly lighter than your surrounding skin tone, making it easy to overlook, especially on lighter skin. Over weeks to months, the area loses more color until it appears distinctly white. The patches are flat, not raised or textured differently from normal skin. They can be as small as a pencil eraser or, less commonly, spread quickly to cover a larger area.
The most common starting locations are the backs of the hands, the face (particularly around the eyes and mouth), the forearms, and the feet. The tissues lining the inside of the mouth and nose can also lose pigment. In most people, patches appear symmetrically on both sides of the body, so if one hand is affected, the other typically follows. A less common form, called segmental vitiligo, stays confined to one side or one area of the body, such as one leg or one side of the face.
What Happens Inside the Skin
The white patches form because melanocytes, the cells responsible for producing skin pigment, are destroyed. This destruction happens in stages, beginning with a buildup of damaging molecules called reactive oxygen species. Think of it as a form of cellular stress: the melanocytes accumulate a level of internal damage they can’t repair.
In healthy skin, cells have a built-in defense system that neutralizes these damaging molecules. In people with vitiligo, this defense system is impaired. Specifically, a key protective pathway that activates antioxidant enzymes doesn’t work properly in their melanocytes, leaving the cells far more vulnerable to oxidative damage. Research on vitiligo patients has confirmed that levels of one critical protective enzyme are significantly lower in their blood compared to healthy controls.
Once melanocytes are stressed and begin to break down, they release fragments that act like alarm signals to the immune system. The immune system then misidentifies healthy melanocytes as threats. A specific type of immune cell, called a CD8+ T cell, carries out the final attack on melanocytes using the same tools the body normally reserves for fighting infected cells. These immune cells can also take up residence in the skin as “memory” cells, which is one reason vitiligo tends to recur in the same locations.
Triggers That Set It Off
Vitiligo requires an underlying genetic susceptibility, but something in the environment or in a person’s life usually sets the process in motion. Several well-documented triggers can spark the first patches or cause existing ones to spread.
- Physical skin trauma: Burns, friction, insect bites, surgical incisions, and even allergic skin reactions can cause new white patches to develop at the exact site of injury. This is known as the Koebner phenomenon, and it explains why vitiligo sometimes first appears in areas exposed to repeated rubbing, like the wrists under a watchband or the waistline under a belt.
- Sunburn: Severe sun exposure can damage already-vulnerable melanocytes and trigger depigmentation in new areas.
- Chemical exposure: Certain industrial chemicals, particularly phenol-based compounds found in some cleaning products, hair dyes, and rubber products, can be directly toxic to melanocytes.
- Psychological stress: Major life stressors like the death of a family member or serious financial problems are frequently reported before the first appearance of vitiligo, particularly in adults. Stressful events appear more commonly before adult-onset cases than childhood-onset cases, suggesting stress plays a stronger triggering role later in life.
The Role of Genetics
Vitiligo runs in families, though it doesn’t follow a simple inheritance pattern. Having a parent or sibling with vitiligo increases your risk, but most people with the condition have no family history at all. The genetic picture involves dozens of genes, many of which overlap with other autoimmune conditions like type 1 diabetes and autoimmune thyroid disease.
One particularly well-studied gene is NLRP1, which controls part of the body’s inflammatory response. People who carry high-risk versions of this gene produce nearly twice as much of a key inflammatory protein from their immune cells, even at rest. This creates a baseline state of heightened immune activity that makes it easier for the autoimmune process to get started once a trigger occurs. The same gene variants also increase risk for other autoimmune diseases, which is why vitiligo often appears alongside conditions like thyroid disorders.
How It Progresses After Starting
The two forms of vitiligo follow very different paths after the initial patches appear. Non-segmental vitiligo, the common symmetric type, tends to alternate between active periods of spreading and stable periods where nothing changes. On average, active phases last a little under a year, and stable phases are slightly longer, but reactivation is the norm. Studies show that 80 to 100% of people with non-segmental vitiligo experience reactivation regardless of how long the disease has been stable.
Segmental vitiligo behaves differently. It tends to spread within its limited area for a shorter active period, then stabilize for much longer stretches. About 71% of the total disease duration is spent in a stable phase. If the condition has been stable for more than two years, the odds of it reactivating drop significantly, to about one-fifth the likelihood compared to those with shorter periods of stability.
Some people experience a rapid, dramatic loss of pigment over a short period. Others notice only a single small patch that stays the same size for years. There’s no reliable way to predict at the outset which pattern you’ll follow, though the type of vitiligo (segmental versus non-segmental) gives a general sense of what to expect. In either case, the color loss itself is painless, though some people report mild itching in areas where new patches are forming.